Management of the brain-dead organ donor: A systematic review and meta-analysis

Transplantation

Volumn 95, Issue 7, 2013, Pages 966-974

  Rech, Tatiana H ^a   Moraes, Rafael B ^a   Crispim, Daisy ^a   Czepielewski, Mauro A ^a   Leitão, Cristiane B ^a  

^a HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

Author keywords

Brain death; Directed tissue donation; Randomized controlled trials; Tissue and organ procurement

Indexed keywords

ADRENALIN; DESMOPRESSIN; DOPAMINE; EURO COLLINS SOLUTION; HETASTARCH; HYDROCORTISONE; HYPERTENSIVE AGENT; LIOTHYRONINE; METHYLPREDNISOLONE; PLACEBO;

ACUTE GRAFT REJECTION; ARTICLE; ARTIFICIAL VENTILATION; BRAIN DEATH; BRAIN SURGERY; FLUID THERAPY; GRAFT RECIPIENT; GRAFT SURVIVAL; HEMODYNAMIC PARAMETERS; HEMODYNAMICS; HORMONE SUBSTITUTION; HUMAN; HYPOTENSION; ISCHEMIC PRECONDITIONING; KIDNEY FUNCTION; LIVER ISCHEMIA; LOW DRUG DOSE; META ANALYSIS; ORGAN DONOR; PATIENT CARE; PRIORITY JOURNAL; PULMONARY VENTILATOR; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK BENEFIT ANALYSIS; SYSTEMATIC REVIEW; TREATMENT OUTCOME;

BRAIN DEATH; DEAMINO ARGININE VASOPRESSIN; FLUID THERAPY; HEMODYNAMICS; HORMONE REPLACEMENT THERAPY; HUMANS; METHYLPREDNISOLONE; RESPIRATION, ARTIFICIAL; TISSUE AND ORGAN HARVESTING; TISSUE AND ORGAN PROCUREMENT; TISSUE DONORS; TRANSPLANTS; TRIIODOTHYRONINE; VASOCONSTRICTOR AGENTS;

EID: 84876217449     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e318283298e     Document Type: Article

References (54)

1. DuBose J, Salim A. Aggressive organ donor management protocol. J Intensive Care Med 2008; 23: 367.
2. Joshi NR, Margulies DR. Aggressive organ donor management: more from less? Curr Opin Organ Transplant 2006; 11: 141.
3. Kusaka M, Pratschke J, Wilhelm MJ, et al. Activation of inflammatory mediators in rat renal isografts by donor brain death. Transplantation 2000; 69: 405.
4. Nijboer WN, Schuurs TA, van der Hoeven JA, et al. Effects of brain death on stress and inflammatory response in the human donor kidney. Transplant Proc 2005; 37: 367.
5. Wood KE, Becker BN, McCartney JG, et al. Care of the potential organ donor. N Engl J Med 2004; 351: 2730.
6. Novitzky D, Cooper DK, Chaffin JS, et al. Improved cardiac allograft function following triiodothyronine therapy to both donor and recipient. Transplantation 1990; 49: 311.
7. Salim A, Vassiliu P, Velmahos GC, et al. The role of thyroid hormone administration in potential organ donors. Arch Surg 2001; 136: 1377.
8. Rosendale JD, Kauffman HM, McBride MA, et al. Aggressive pharma-cologic donor management results in more transplanted organs. Transplantation 2003; 75: 482.
9. Goarin JP, Cohen S, Riou B, et al. The effects of triiodothyronine on hemodynamic status and cardiac function in potential heart donors. Anesth Analg 1996; 83: 41.
10. Mariot J, Jacob F, Voltz C, et al. Interet de l'hormonotherapie associant triiodothyronine et cortisone chez le patient en etat de mort cerebrale [Value of hormonal treatment with triiodothyronine and cortisone in brain dead patients]. Ann Fr Anesth Reanim 1991; 10: 321.
11. Rech TH, Rodrigues Filho EM. Manuseio do potencial doador de múltiplos órgãos. Rev Bras Ter Intensiva 2007; 19: 197.
12. Bugge JF. Brain death and its implications for management of the potential organ donor. Acta Anaesthesiol Scand 2009; 53: 1239.
13. Venkateswaran RV, Patchell VB, Wilson IC, et al. Early donor management increases the retrieval rate of lungs for transplantation. Ann Thorac Surg 2008; 85: 278; discussion 86.
14. Zaroff JG, Rosengard BR, Armstrong WF, et al. Consensus conference report: Maximizing use of organs recovered from the cadaver donor: cardiac recommendations, March 28-29, 2001, Crystal City, Va. Circulation 2002; 106: 836.
15. Rosendale JD, Chabalewski FL, McBride MA, et al. Increased transplanted organs from the use of a standardized donor management protocol. Am J Transplant 2002; 2: 761.
16. Westphal GA, Caldeira Filho M, Vieira KD, et al. Guidelines for potential multiple organ donors (adult). Part II. Mechanical ventilation, endocrine metabolic management, hematological and infectious aspects. Rev Bras Ter Intensiva 2001; 23: 269.
17. Chatterjee SN, Terasaki PI, Fine S, et al. Pretreatment of cadaver donors with methylprednisolone in human renal allografts. Surg Gynecol Obstet 1977; 145: 729.
18. Cittanova ML, Leblanc I, Legendre C, et al. Effect of hydroxyethylstarch in brain-dead kidney donors on renal function in kidney-transplant recipients. Lancet 1996; 348: 1620.
19. Cofer JB, Klintmalm GB, Morris CV, et al. A prospective randomized trial between Euro-Collins and University of Wisconsin solutions as the initial flush in hepatic allograft procurement. Transplantation 1992; 53: 995.
20. D'Amico F, Vitale A, Gringeri E, et al. Liver transplantation using suboptimal grafts: impact of donor harvesting technique. Liver Transpl 2007; 13: 1444.
21. Iwai A, Sakano T, Uenishi M, et al. Effects of vasopressin and cate-cholamines on the maintenance of circulatory stability in brain-dead patients. Transplantation 1989; 48: 613.
22. Jeevanandam V. Triiodothyronine: spectrum of use in heart transplantation. Thyroid 1997; 7: 139.
23. Kotsch K, Ulrich F, Reutzel-Selke A, et al. Methylprednisolone therapy in deceased donors reduces inflammation in the donor liver and improves outcome after liver transplantation: a prospective randomized controlled trial. Ann Surg 2008; 248: 1042.
24. Mascia L, Pasero D, Slutsky AS, et al. Effect of a lung protective strategy for organ donors on eligibility and availability of lungs for transplantation: a randomized controlled trial. JAMA 2010; 304: 2620.
25. Randell T, Orko R, Hockerstedt K. Peroperative fluid management of the brain-dead multiorgan donor. Acta Anaesthesiol Scand 1990; 34: 592.
26. Randell TT, Hockerstedt KA. Triiodothyronine treatment in brain-dead multiorgan donorsVa controlled study. Transplantation 1992; 54: 736.
27. Schnuelle P, Gottmann U, Hoeger S, et al. Effects of donor pre-treatment with dopamine on graft function after kidney transplantation: a randomized controlled trial. JAMA 2009; 302: 1067.
28. Amador A, Grande L, Marti J, et al. Ischemic pre-conditioning in deceased donor liver transplantation: a prospective randomized clinical trial. Am J Transplant 2007; 7: 2180.
29. Azoulay D, Del Gaudio M, Andreani P, et al. Effects of 10 minutes of ischemic preconditioning of the cadaveric liver on the graft's preservation and function: the ying and the yang. Ann Surg 2005; 242: 133.
30. Guesde R, Barrou B, Leblanc I, et al. Administration of desmopressin in brain-dead donors and renal function in kidney recipients. Lancet 1998; 352: 1178.
31. Pennefather SH, Bullock RE, Mantle D, et al. Use of low dose argi-nine vasopressin to support brain-dead organ donors. Transplantation 1995; 59: 58.
32. Perez-Blanco A, Caturla-Such J, Canovas-Robles J, et al. Efficiency of triiodothyronine treatment on organ donor hemodynamic management and adenine nucleotide concentration. Intensive Care Med 2005; 31: 943.
33. Venkateswaran RV, Steeds RP, Quinn DW, et al. The haemodynamic effects of adjunctive hormone therapy in potential heart donors: a prospective randomized double-blind factorially designed controlled trial. Eur Heart J 2009; 30: 1771.
34. Novitzky D, Wicomb WN, Cooper DKC, et al. Electrocardiographic, hemodynamic and endocrine changes occurring during experimental brain death in the chacma baboon. J Heart Transplant 1984; 4: 63.
35. Novitzky D, Cooper DK, Reichart B. Hemodynamic and metabolic responses to hormonal therapy in brain-dead potential organ donors. Transplantation 1987; 43: 852.
36. Rosendale JD, Kauffman HM, McBride MA, et al. Hormonal resuscitation yields more transplanted hearts, with improved early function. Transplantation 2003; 75: 1336.
37. Macdonald PS, Aneman A, Bhonagiri D, et al. A systematic review and meta-analysis of clinical trials of thyroid hormone administration to brain dead potential organ donors. Crit Care Med 2012; 40: 1635.
38. Stathatos N, Levetan C, Burman KD, et al. The controversy of the treatment of critically ill patients with thyroid hormone. Best Pract Res Clin Endocrinol Metab 2001; 15: 465.
39. Dictus C, Vienenkoetter B, Esmaeilzadeh M, et al. Critical care management of potential organ donors: our current standard. Clin Transplant 2009; 23: 2.
40. Pennefather SH, Bullock RE, Dark JH. The effect of fluid therapy on alveolar arterial oxygen gradient in brain-dead organ donors. Transplantation 1993; 56: 1418.
41. Gattas DJ, Dan A, Myburgh J, et al. Fluid resuscitation with 6% hydroxyethyl starch (130/0.4) in acutely ill patients: an updated systematic review and meta-analysis. Anesth Analg 2012; 114: 159.
42. De Backer D, Aldecoa C, Njimi H, et al. Dopamine versus norepi-nephrine in the treatment of septic shock: a meta-analysis. Crit Care Med 2012; 40: 725.
43. Jassem W, Fuggle SV, Cerundolo L, et al. Ischemic preconditioning of cadaver donor livers protects allografts following transplantation. Transplantation 2006; 81: 169.
44. Follette DM, Rudich SM, Babcock WD. Improved oxygenation and increased lung donor recovery with high-dose steroid administration after brain death. J Heart Lung Transplant 1998; 17: 423.
45. Dimopoulou I, Tsagarakis S, Anthi A, et al. High prevalence of decreased cortisol reserve in brain-dead potential organ donors. Crit Care Med 2003; 31: 1113.
46. Amato MB, Barbas CS, Medeiros DM, et al. Effect of a protective- ventilation strategy on mortality in the acute respiratory distress syndrome. N Engl J Med 1998; 338: 347.
47. Brower RG, Lanken PN, MacIntyre N, et al. Higher versus lower positive end-expiratory pressures in patients with the acute respiratory distress syndrome. N Engl J Med 2004; 351: 327.
48. Balshem H, Helfand M, Schunemann HJ, et al. GRADE guidelines: 3. Rating the quality of evidence. J Clin Epidemiol 2011; 64: 401.
49. Powner DJ, Darby JM, Kellum JA. Proposed treatment guidelines for donor care. Prog Transplant 2004; 14: 16; quiz 7-8.
50. Robinson KA, Dickersin K. Development of a highly sensitive search strategy for the retrieval of reports of controlled trials using PubMed. Int J Epidemiol 2002; 31: 150.
51. Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med 2009; 151: 264.
52. Peters JL, Sutton AJ, Jones DR, et al. Contour-enhanced meta-analysis funnel plots help distinguish publication bias from other causes of asymmetry. J Clin Epidemiol 2008; 61: 991.
53. Higgins JP, Thompson SG, Deeks JJ, et al. Measuring inconsistency in meta-analyses. BMJ 2003; 327: 557.
54. Duval S, Tweedie R. Trim and fill: a simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics 2000; 56: 455.